首页 | 本学科首页   官方微博 | 高级检索  
检索        

干扰素和环孢霉素A 协同逆转K562/ ADM细胞对阿霉素的耐药性
引用本文:魏虎来,葛建国,赵怀顺,王东海,白德成.干扰素和环孢霉素A 协同逆转K562/ ADM细胞对阿霉素的耐药性[J].肿瘤防治研究,2005,32(2):99-101.
作者姓名:魏虎来  葛建国  赵怀顺  王东海  白德成
作者单位:730000,兰州大学医学实验中心,甘肃省中药新药临床前研究重点实验室
基金项目:甘肃省中青年科技基金,甘肃省培养造就跨世纪学术技术带头人专项基金
摘    要:  目的 观察干扰素(α-Interleron,α-IFN)和环孢霉素A(Cyclosporine A,CsA)对白血病K562/ADM细胞耐药性的协同逆转效应。方法 以多药耐药基因/P-糖蛋白(Muhidrug resistance gene/P-glycoprotein,mdrl/P-gp)超表达的K562/ADM细胞为靶细胞,MTT比色法检测药物的细胞毒效应;流式细胞仪检测细胞P-糖蛋白(P-glycoprotein,P-gp)表达水平;激光共聚焦显微镜观察细胞内阿霉素含量变化。结果 K562/ADM细胞对阿霉素呈高度耐药性,并与柔红霉素和鬼臼乙叉甙交叉耐药,但与CsA无交叉耐药。CsA和α-IFN单独或联合应用均对K562/ADM细胞的耐药性有较强的抑制效应。流式细胞仪和激光共聚焦显微镜分析发现α-IFN和CsA单独或联合均不能下调细胞mdrl/P-gp的表达,反而应激性地刺激耐药细胞P-gp的合成增加,但可抑制P-gp的功能、增加K562/ADM细胞内阿霉素的积聚。结论 α-IFN和CsA联合可协同逆转耐药白血病细胞的耐药性,其作用机制为抑制P-gp的功能而非下调mdrl/P-gp的表达水平。

关 键 词:α-干扰素  环孢霉素A  白血病  多药耐药  协同  逆转
文章编号:1000-8578(2005)02-0099-03
收稿时间:2004-2-10
修稿时间:2004-3-25

Synergistic Reversal of Multidrug Resistance of Leukemia Cells by α-Interferon and Cyclosporine A
WEI Hu-lai,GE Jian-guo,ZHAO Huai-shun,WANG Dong-hai,BAI De-cheng.Synergistic Reversal of Multidrug Resistance of Leukemia Cells by α-Interferon and Cyclosporine A[J].Cancer Research on Prevention and Treatment,2005,32(2):99-101.
Authors:WEI Hu-lai  GE Jian-guo  ZHAO Huai-shun  WANG Dong-hai  BAI De-cheng
Institution:Laboratory Center for Medical Science , Lanzhou Universit y ; Key Laboratory of Preclinical Study for New Chinese T radi tional Drugs of Gansu Province , Lanz hou 730000 , China
Abstract:Objective  To investigate the synergistic reversal effect of α-Interferon (α2IFN) and Cyclosporine A (CsA) on the multidrug-resistance of human leukemia K562/ ADM cells. Methods  Human leukemia K562/ ADM cell that overexpresses P-glycoprotein ( P-gp) encoded by human multidrug resistance gene (mdr1) was used as the target cells. The α-IFN2 or / and CsA-administ rated K562/ ADM cells were analyzed for proliferation and sensitivity to adriamycin using MTT method , P-gp expression was determined by flow cytomet ry , and the int racellular adriamycin accumulation was examined by confocal laserscanning fluorescence microscopy. Results  K562/ ADM cells were highly resistant to adriamycin , and cross-resistant to daunorubicin and etoposide , but uncross-resistant to CsA. CsA ,α-IFN orα-IFN plus CsA both significantly decreased the drug-resistance of K562/ ADM cells to adriamycin. Cytometric and confocal microscopic analysis showed that CsA and α-IFN did not down-regulate the mdr1/ P-gp expression in K562/ ADM cells , and cont rarily exerted a stress-activated increase of P-gp synthesis , but they could inhibit the pump function of P-gp and increase the adriamycin accumulation inK562/ADM cells.Conclusion  α-IFN combined with CsA synergistically reverse the multidrug-resistance of K562/ ADM cells and increase their sensitivity to conventional chemotherapeutic agents via the inhibition of pump function of P-glycoprotein not down-regulation of it s expression.
Keywords:α-Interferon  Cyclosporine A  Leukemia  Multidrug resistance (MDR)  Synergism  Reversal
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号